ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0793

Topological Laser Capture Microscopy (LCM)-RNAseq to Map the Rheumatoid Arthritis (RA) Synovial Transcriptome

Benjamin Van Espen1, Andrew Wilson1, Gregory Seumois2, Narayanan Perumal3, Robert Benschop4, Gary Firestein5, Nunzio Bottini5 and Stephanie Stanford1, 1University of California, San Diego, La Jolla, 2La Jolla Institute for Immunology, La Jolla, 3Eli Lilly, Indianapolis, 4Eli Lilly and Company, Indianapolis, IN, 5University of California, San Diego, La Jolla, CA

Meeting: ACR Convergence 2020

Keywords: Fibroblasts, Synovial, Pathology Bone Joint, rheumatoid arthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Understanding pathogenic processes in the diseased tissue in rheumatoid arthritis (RA) is a critical step to defining disease pathogenesis and identifying novel therapeutic targets. However, the use of enzymatically dispersed cells can lead to changes in the gene transcription and bias due to cell death. Therefore, we established laser capture microscopy followed by RNAseq (LCM-RNAseq) to study the regional transcriptome.

Methods: Synovial tissue was captured by LCM after H&E staining from lining, sublining, and blood vessels from 3 RA and 3 osteoarthritis (OA) patients. RNA was extracted and subjected to RNAseq. Principal component analysis (PCA) by disease state was performed on the top 500 most variable genes among the sample set. Analysis of differentially expressed genes (DEGs) between disease state was performed using the Bioconductor DESeq2 package. DEGs had adjusted p-values of < 0.05 and log2 fold change >1 or < -1. Pathway analysis on the unique DEGs for each substructure was performed using the Canonical Pathways function in Ingenuity Pathway Analysis (IPA) platform. The significance of the pathways was calculated using a right-tailed Fisher’s exact test and adjusted using the Benjamini-Hochberg method.

Results: PCA revealed striking separation between RA and OA transcriptomes (see Figure), indicating that the transcriptomes could be readily distinguished. Pairwise comparisons of synovial lining, sublining and blood vessels between RA and OA revealed substantial differences in transcriptional patterns between each region. Pathway analysis of DEGs unique to each substructure revealed that each region displayed distinct phenotypic abnormalities in RA. For example, RA synovial lining was marked by anomalies of innate immunity, including Role of Pattern Recognition Receptors in Recognition of Bacteria and Virus (p< 0.001) and LPS/IL-1 Mediated Inhibition of RXR Function (p< 0.01) pathways. Intriguingly, RA sublining abnormalities were primarily in metabolic pathways involving fatty acid regulation, such as Fatty Acid Activation (p< 0.01) and Mitochondrial L-carnitine Shuttle Pathway (p< 0.01). RA synovial vessels displayed evidence of alterations in pathways indicative of dysregulated angiogenesis, including Melatonin Signaling (p< 0.0001) and Apelin Cardiomyocyte Signaling (p< 0.001).

Conclusion: Through use of LCM, we established a method for RNAseq-quality extraction of RNA and showed large differences between RA and OA synovial substructures that are difficult to detect using single cell analysis. This technology can supplement disaggregation techniques to provide key information on in situ gene expression profiles and identify disease and substructure-specific targets for RA.


Disclosure: B. Van Espen, Eli Lilly, 2; A. Wilson, Eli Lilly, 2; G. Seumois, None; N. Perumal, Eli Lilly and Company, 1, 3; R. Benschop, Eli Lilly and Company, 1, 3, 4; G. Firestein, Eli Lilly, 2; N. Bottini, Gilead Sciences, 2, Kyowa Kirin Pharmaceutical Research, 2, Eli Lilly, 2; S. Stanford, Eli Lilly, 2.

To cite this abstract in AMA style:

Van Espen B, Wilson A, Seumois G, Perumal N, Benschop R, Firestein G, Bottini N, Stanford S. Topological Laser Capture Microscopy (LCM)-RNAseq to Map the Rheumatoid Arthritis (RA) Synovial Transcriptome [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/topological-laser-capture-microscopy-lcm-rnaseq-to-map-the-rheumatoid-arthritis-ra-synovial-transcriptome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/topological-laser-capture-microscopy-lcm-rnaseq-to-map-the-rheumatoid-arthritis-ra-synovial-transcriptome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology